Results 71 to 80 of about 11,994 (242)

The activity of micafungin against clinical isolates of non-albicans Candida spp.

Current Issues in Pharmacy and Medical Sciences, 2015
Infections caused by non-albicans Candida spp. are an important medical problem in people from risk groups, e.g. hematooncological patients. The aim of this paper was to analyse the in vitro activity of micafungin against 30 clinical isolates of non ...
Biernasiuk Anna, Dobiecka Ewelina, Zdzienicka Grazyna, Malm Anna   +3 more
doaj   +1 more source

‘Case of the Month’ from Herlev and Gentofte Hospital, Denmark: candidaemia and fungus ball in a patient with diabetes on sodium‐glucose co‐transporter 2 inhibitor

BJU International, EarlyView.
Anne Sofie Frøkiær Mathiasen, Maria Feldborg Bruun Andersen, Valeria Antsupova, Mikkel Fode   +3 more
wiley   +1 more source

Endogenous Ethanol Production in the Human Alimentary Tract: A Literature Review

Journal of Gastroenterology and Hepatology, Volume 40, Issue 4, Page 783-790, April 2025.
ABSTRACT Endogenous ethanol production, or auto‐brewery syndrome (ABS), is a rare condition of the human alimentary canal that results in intoxication without alcohol consumption. Despite its clinical significance, ABS remains largely undiagnosed because of a lack of awareness among clinicians.
Renee Stamation
wiley   +1 more source

Çocuklarda Mikafungin Kullanımının Değerlendirilmesi

Mikrobiyoloji Bulteni, 2020
Micafungin is recommended especially in patients with liver and kidney failure and in the presence of other side effects due to antifungals apart from its known priority indications such as invasive candidiasis. The aim of this study was to evaluate the children who have received micafungin treatment. In the study, 125 children who were hospitalized in
Edanur Yeşil, Solmaz Çelebi, Melike Sezgin Evim, Arife Özer, Cansu Turan, Demet Timur, Salih Çağrı Çakır, Beyhan Bülbül, Beyza Ener, Adalet Meral Güneş, Nilgün Köksal, Hilal Özkan, Betül Sevinir, Duygu Düzcan Kilimci, Mustafa Hacımustafaoğlu   +14 more
openaire   +4 more sources

Antifungal Resistance in Non‐fumigatus Aspergillus Species

Mycoses, Volume 68, Issue 4, April 2025.
ABSTRACT This review provides an in‐depth exploration of antifungal resistance in non‐fumigatus Aspergillus species, mainly focusing on acquired resistance. The available data have been compiled and sometimes re‐analysed. It highlights the increasing prevalence of resistance in non‐fumigatus species belonging to Flavi, Terrei, Nigri, and Nidulantes ...
Elie Djenontin, Rose‐Anne Lavergne, Florent Morio, Eric Dannaoui   +3 more
wiley   +1 more source

Assessment of the feed additive consisting of Saccharomyces cerevisiae NCYC R404 for dairy cows for the renewal of its authorisation (Volac International Ltd)

EFSA Journal, Volume 23, Issue 4, April 2025.
Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of the authorisation of Saccharomyces cerevisiae NCYC R404 as a zootechnical additive (functional group: gut flora stabilisers) for dairy cows.
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Roberto Edoardo Villa, Giovanna Azimonti, Eleftherios Bonos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Ronette Gehring, Boet Glandorf, Maryline Kouba, Marta López‐Alonso, Francesca Marcon, Carlo Nebbia, Alena Pechová, Miguel Prieto‐Maradona, Ilen Röhe, Katerina Theodoridou, Andrey Yurkov, Montserrat Anguita, Nicole Bozzi Cionci, Rosella Brozzi, Yolanda García‐Cazorla, Jordi Tarrés‐Call, Piera Valeri, Matteo L. Innocenti   +24 more
wiley   +1 more source

Micafungin in the treatment of candiduria: A case series

Medical Mycology Case Reports, 2016
Echinocandin antifungal agents are not routinely recommended for the treatment of candiduria due to low urine concentrations and a paucity of clinical data supporting this indication. This report presents five cases describing the use of micafungin for the treatment of candiduria.
Katie M. Muzevich, Lauren E. Kane
openaire   +4 more sources

A case of invasive pulmonary aspergillosis associated with clozapine‐induced agranulocytosis

Psychiatry and Clinical Neurosciences Reports, Volume 4, Issue 1, March 2025.
Abstract Background Clozapine‐induced agranulocytosis (CLIA) is a rare but serious complication. Fever associated with CLIA is typically treated with broad‐spectrum antimicrobials, but empiric antifungal therapy is rarely used. While bacterial and viral infections have been reported in CLIA cases, no cases of fungal infections complicated by CLIA have ...
Akiyoshi Yokode, Masaki Fujiwara, Toshiki Terao, Shinji Sakamoto, Yuto Yamada, Ryota Sato, Momoko Mishima, Yuji Yada, Ken‐Ichi Matsuoka, Manabu Takaki   +9 more
wiley   +1 more source

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication

BMC Infectious Diseases, 2018
Background To compare the risk of severe hepatotoxicity with anidulafungin versus caspofungin and micafungin in hospitalized adults. Methods This retrospective cohort study combined data from two large US- based hospital electronic medical record ...
Francis Vekeman, Lisa Weiss, Jalal Aram, Raluca Ionescu-Ittu, Shahrzad Moosavi, Yongling Xiao, Wendy Y. Cheng, Rachel H. Bhak, Margaret Tawadrous, M. Rita Capparella, Philippe Montravers, Mei Sheng Duh   +11 more
doaj   +1 more source

In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism

Antimicrobial Agents and Chemotherapy, 2019
Candida auris is an emerging, multidrug-resistant pathogen responsible for invasive hospital-acquired infections. Flucytosine is an effective anti-Candida species drug, but which cannot be used as a monotherapy because of the risk of development of ...
A. Bidaud, F. Botterel, A. Chowdhary, Eric Dannaoui   +3 more
semanticscholar   +1 more source